Outlook Therapeutics Inc (NASDAQ:OTLK)

1.18
Delayed Data
As of Sep 27
 +0.03 / +2.61%
Today’s Change
0.68
Today|||52-Week Range
2.35
-13.24%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Outlook Therapeutics Inc have a median target of 6.50, with a high estimate of 10.00 and a low estimate of 6.00. The median estimate represents a +450.85% increase from the last price of 1.18.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Outlook Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.07
Sales
$0.00
Reporting Date
Dec 21

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 12.50%
 
 
 
 
 
 
Growthannually 15.00%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.